For the Inventor, By the Inventor

Enter assignee name

Emeryville, CA, United States of America

Zymergen Inc.

USPTO Granted Patents = 57

% Expired Patents = 35.1

CIPO Patents = 1

EPO Patents = 5

Trademarks = 5

Forward Citations = 275

Loading Chart...

Loading Chart...

108 inventors (with patents filed for the assignee):

Shawn Manchester (20 out of 20 patents)

Kenneth S Bruno (20 out of 20 patents)

Shawn Szyjka (19 out of 19 patents)

4. Erik Jedediah Dean (17 out of 18 patents)

5. Aaron Kimball (17 out of 19 patents)

6. Barbara Frewen (17 out of 17 patents)

7. Katherine Gora (16 out of 16 patents)

8. Erin Shellman (15 out of 15 patents)

9. Michael Flashman (15 out of 18 patents)

10. Thomas Treynor (15 out of 15 patents)

11. Zach Serber (11 out of 16 patents)

12. Zachariah Serber (9 out of 9 patents)

13. Sara Da Luz Areosa Cleto (7 out of 7 patents)

14. Jeffrey Kim (6 out of 28 patents)

15. Oliver Liu (6 out of 19 patents)

Core Competencies:

Bioreachable Chiral Dopants

Biosynthetic Pathways

High-Throughput Genomic Engineering

Gene Clusters

Microbial Strain Improvement

CRISPRi Applications

Electroporation Methods

Metagenomic Library

Signal Transduction

NADPH Production

Insecticidal Proteins

DNA Library Assembly

57 patents: Sort by Forward Citations

1. 11814563 - Bioreachable chiral dopants for liquid crystal applications (2023-11-14),

2. 11739355 - Engineered biosynthetic pathways for production of histamine by fermentation (2023-08-29),

3. 11618898 - Compositions and methods for activating silent gene clusters (2023-04-04),

4. 11581064 - Device-agnostic system for planning and executing high-throughput genomic manufacturing operations (2023-02-14),

5. 11574153 - Identifying organisms for production using unsupervised parameter learning for outlier detection (2023-02-07),

6. 11549096 - Genetic perturbation of the RNA degradosome protein complex (2023-01-10),

7. 11519012 - Genomic engineering of biosynthetic pathways leading to increased NADPH (2022-12-06),

8. 11495326 - Metagenomic library and natural product discovery platform (2022-11-08),

9. 11479779 - Systems and methods for high-throughput automated strain generation for non-sporulating fungi (2022-10-25),

10. 11466242 - Apparatuses and methods for electroporation (2022-10-11),

11. 11452967 - Metal-organic framework materials (2022-09-27),

12. 11352621 - HTP genomic engineering platform (2022-06-07),

13. 11312951 - Systems and methods for host cell improvement utilizing epistatic effects (2022-04-26),

14. 11299753 - Method for counterselection in microorganisms (2022-04-12),

15. 11299741 - Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production (2022-04-12),

Company Overview

Zymergen Inc., headquartered in Emeryville, California, specializes in genomic engineering, focusing on the development of innovative biotechnological solutions. The company leverages advanced techniques such as high-throughput genomic engineering and CRISPRi applications to enhance microbial strain improvement and biosynthetic pathways. Zymergen's research encompasses the creation of bioreachable chiral dopants and the utilization of metagenomic libraries, positioning it at the forefront of synthetic biology and biomanufacturing.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

57 Patents

#11 in Emeryville, CA

#1,466 in California

#6,252 in US

#12,573 in the World

Emeryville, CA, United States of America

Zymergen Inc.

Forward Citations = 275

108 inventors:

Shawn Manchester (20 out of 20 patents)

Kenneth S Bruno (20 out of 20 patents)

Shawn Szyjka (19 out of 19 patents)

4. Erik Jedediah Dean (17 out of 18 patents)

5. Aaron Kimball (17 out of 19 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Zymergen Inc.. Retrieved from https://idiyas.com/company/zymergen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…